Table 7 Outcomes and outcome measurements identified in the ‘Adverse events’ domain for PGP and LPP respectively
Adverse Events | PGP studies (n = 33) | LPP studies (74) |
|---|---|---|
Adverse events (not specified) | Patient Questionnaire [115] | Case reports by physio [86] Identified by trialist [12] |
Post-op complications | Not specified [117] | Â |
Fetal outcome | Â | Apgar score, birth weight, perinatal loss [84] |
Safety of women and children | Â | Not specified [114] |